🔎 Trials Near Me

Beranda › Limfoma Burkitt › Utah › Salt Lake City

Uji klinis Limfoma Burkitt di Salt Lake City, UT

7 studi untuk Limfoma Burkitt mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Menerima pesertaFase 1
  • Primary Children's Hospital, Salt Lake City
Usia 0 hingga 18 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06173518

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Menerima pesertaFase 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Usia 18 hingga 39 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Menerima pesertaFase 2
  • Primary Children's Hospital, Salt Lake City
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Menerima pesertaFase 3
  • Primary Children's Hospital, Salt Lake City
365 Days – 25 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Menerima pesertaFase 2
  • Primary Children's Hospital, Salt Lake City
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519

Uji klinis Limfoma Burkitt di kota lain

Studi lain di Salt Lake City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.